Podocyte and endothelial cell injury lead to nephrotic syndrome in proliferative lupus nephritis

Aims Nephrotic syndrome (NS) is a major manifestation of lupus nephritis (LN). The dysregulation of podocytes, the glomerular basement membrane (GBM) and endothelial cells (ECs) results in proteinuria in glomerular diseases. The aim of our study was to clarify whether the dysregulation of these barr...

Full description

Saved in:
Bibliographic Details
Published inHistopathology Vol. 72; no. 7; pp. 1084 - 1092
Main Authors Nawata, Aya, Hisano, Satoshi, Shimajiri, Shohei, Wang, Ke‐Yong, Tanaka, Yoshiya, Nakayama, Toshiyuki
Format Journal Article
LanguageEnglish
Published England Wiley 01.06.2018
Wiley Subscription Services, Inc
Subjects
Online AccessGet full text
ISSN0309-0167
1365-2559
1365-2559
DOI10.1111/his.13454

Cover

Abstract Aims Nephrotic syndrome (NS) is a major manifestation of lupus nephritis (LN). The dysregulation of podocytes, the glomerular basement membrane (GBM) and endothelial cells (ECs) results in proteinuria in glomerular diseases. The aim of our study was to clarify whether the dysregulation of these barriers is associated with NS in proliferative LN and membranous LN. Methods and results Fifty‐six patients with NS, including minimal change NS in 15, primary membranous nephropathy (PMN) in 13, class III/IV LN in 15, and class V LN in 13, were enrolled in this study. Subjects with idiopathic haematuria were assigned as controls. Glomerular expression of Wilms tumour protein 1 (WT1), nephrin, synaptopodin and podocalyxin was evaluated by immunohistochemistry (IHC) and real‐time quantitative reverse transcription polymerase chain reaction. EC injury was evaluated by CD31 immunostaining and electron microscopy (EM). Reduced expression of WT1, nephrin and synaptopodin was found in PMN, class III/IV LN and class V LN as compared with controls by IHC and mRNA analysis. Reduced expression of these molecules was not different between class III/IV LN and class V LN. Reduced numbers of CD31‐positive ECs were found in class III/IV LN as compared with class V LN. EC injury showing subendothelial widening on EM was apparent in class III/IV LN as compared with class V LN. Foot process effacement was found only along the GBM showing EC injury in class III/IV LN. Conclusions Our study suggests that coexistence of podocyte and EC injury may lead to NS in proliferative LN. Podocyte damage alone leads to NS in membranous LN.
AbstractList Nephrotic syndrome (NS) is a major manifestation of lupus nephritis (LN). The dysregulation of podocytes, the glomerular basement membrane (GBM) and endothelial cells (ECs) results in proteinuria in glomerular diseases. The aim of our study was to clarify whether the dysregulation of these barriers is associated with NS in proliferative LN and membranous LN.AIMSNephrotic syndrome (NS) is a major manifestation of lupus nephritis (LN). The dysregulation of podocytes, the glomerular basement membrane (GBM) and endothelial cells (ECs) results in proteinuria in glomerular diseases. The aim of our study was to clarify whether the dysregulation of these barriers is associated with NS in proliferative LN and membranous LN.Fifty-six patients with NS, including minimal change NS in 15, primary membranous nephropathy (PMN) in 13, class III/IV LN in 15, and class V LN in 13, were enrolled in this study. Subjects with idiopathic haematuria were assigned as controls. Glomerular expression of Wilms tumour protein 1 (WT1), nephrin, synaptopodin and podocalyxin was evaluated by immunohistochemistry (IHC) and real-time quantitative reverse transcription polymerase chain reaction. EC injury was evaluated by CD31 immunostaining and electron microscopy (EM). Reduced expression of WT1, nephrin and synaptopodin was found in PMN, class III/IV LN and class V LN as compared with controls by IHC and mRNA analysis. Reduced expression of these molecules was not different between class III/IV LN and class V LN. Reduced numbers of CD31-positive ECs were found in class III/IV LN as compared with class V LN. EC injury showing subendothelial widening on EM was apparent in class III/IV LN as compared with class V LN. Foot process effacement was found only along the GBM showing EC injury in class III/IV LN.METHODS AND RESULTSFifty-six patients with NS, including minimal change NS in 15, primary membranous nephropathy (PMN) in 13, class III/IV LN in 15, and class V LN in 13, were enrolled in this study. Subjects with idiopathic haematuria were assigned as controls. Glomerular expression of Wilms tumour protein 1 (WT1), nephrin, synaptopodin and podocalyxin was evaluated by immunohistochemistry (IHC) and real-time quantitative reverse transcription polymerase chain reaction. EC injury was evaluated by CD31 immunostaining and electron microscopy (EM). Reduced expression of WT1, nephrin and synaptopodin was found in PMN, class III/IV LN and class V LN as compared with controls by IHC and mRNA analysis. Reduced expression of these molecules was not different between class III/IV LN and class V LN. Reduced numbers of CD31-positive ECs were found in class III/IV LN as compared with class V LN. EC injury showing subendothelial widening on EM was apparent in class III/IV LN as compared with class V LN. Foot process effacement was found only along the GBM showing EC injury in class III/IV LN.Our study suggests that coexistence of podocyte and EC injury may lead to NS in proliferative LN. Podocyte damage alone leads to NS in membranous LN.CONCLUSIONSOur study suggests that coexistence of podocyte and EC injury may lead to NS in proliferative LN. Podocyte damage alone leads to NS in membranous LN.
Aims Nephrotic syndrome (NS) is a major manifestation of lupus nephritis (LN). The dysregulation of podocytes, the glomerular basement membrane (GBM) and endothelial cells (ECs) results in proteinuria in glomerular diseases. The aim of our study was to clarify whether the dysregulation of these barriers is associated with NS in proliferative LN and membranous LN. Methods and results Fifty‐six patients with NS, including minimal change NS in 15, primary membranous nephropathy (PMN) in 13, class III/IV LN in 15, and class V LN in 13, were enrolled in this study. Subjects with idiopathic haematuria were assigned as controls. Glomerular expression of Wilms tumour protein 1 (WT1), nephrin, synaptopodin and podocalyxin was evaluated by immunohistochemistry (IHC) and real‐time quantitative reverse transcription polymerase chain reaction. EC injury was evaluated by CD31 immunostaining and electron microscopy (EM). Reduced expression of WT1, nephrin and synaptopodin was found in PMN, class III/IV LN and class V LN as compared with controls by IHC and mRNA analysis. Reduced expression of these molecules was not different between class III/IV LN and class V LN. Reduced numbers of CD31‐positive ECs were found in class III/IV LN as compared with class V LN. EC injury showing subendothelial widening on EM was apparent in class III/IV LN as compared with class V LN. Foot process effacement was found only along the GBM showing EC injury in class III/IV LN. Conclusions Our study suggests that coexistence of podocyte and EC injury may lead to NS in proliferative LN. Podocyte damage alone leads to NS in membranous LN.
Nephrotic syndrome (NS) is a major manifestation of lupus nephritis (LN). The dysregulation of podocytes, the glomerular basement membrane (GBM) and endothelial cells (ECs) results in proteinuria in glomerular diseases. The aim of our study was to clarify whether the dysregulation of these barriers is associated with NS in proliferative LN and membranous LN. Fifty-six patients with NS, including minimal change NS in 15, primary membranous nephropathy (PMN) in 13, class III/IV LN in 15, and class V LN in 13, were enrolled in this study. Subjects with idiopathic haematuria were assigned as controls. Glomerular expression of Wilms tumour protein 1 (WT1), nephrin, synaptopodin and podocalyxin was evaluated by immunohistochemistry (IHC) and real-time quantitative reverse transcription polymerase chain reaction. EC injury was evaluated by CD31 immunostaining and electron microscopy (EM). Reduced expression of WT1, nephrin and synaptopodin was found in PMN, class III/IV LN and class V LN as compared with controls by IHC and mRNA analysis. Reduced expression of these molecules was not different between class III/IV LN and class V LN. Reduced numbers of CD31-positive ECs were found in class III/IV LN as compared with class V LN. EC injury showing subendothelial widening on EM was apparent in class III/IV LN as compared with class V LN. Foot process effacement was found only along the GBM showing EC injury in class III/IV LN. Our study suggests that coexistence of podocyte and EC injury may lead to NS in proliferative LN. Podocyte damage alone leads to NS in membranous LN.
AimsNephrotic syndrome (NS) is a major manifestation of lupus nephritis (LN). The dysregulation of podocytes, the glomerular basement membrane (GBM) and endothelial cells (ECs) results in proteinuria in glomerular diseases. The aim of our study was to clarify whether the dysregulation of these barriers is associated with NS in proliferative LN and membranous LN.Methods and resultsFifty‐six patients with NS, including minimal change NS in 15, primary membranous nephropathy (PMN) in 13, class III/IV LN in 15, and class V LN in 13, were enrolled in this study. Subjects with idiopathic haematuria were assigned as controls. Glomerular expression of Wilms tumour protein 1 (WT1), nephrin, synaptopodin and podocalyxin was evaluated by immunohistochemistry (IHC) and real‐time quantitative reverse transcription polymerase chain reaction. EC injury was evaluated by CD31 immunostaining and electron microscopy (EM). Reduced expression of WT1, nephrin and synaptopodin was found in PMN, class III/IV LN and class V LN as compared with controls by IHC and mRNA analysis. Reduced expression of these molecules was not different between class III/IV LN and class V LN. Reduced numbers of CD31‐positive ECs were found in class III/IV LN as compared with class V LN. EC injury showing subendothelial widening on EM was apparent in class III/IV LN as compared with class V LN. Foot process effacement was found only along the GBM showing EC injury in class III/IV LN.ConclusionsOur study suggests that coexistence of podocyte and EC injury may lead to NS in proliferative LN. Podocyte damage alone leads to NS in membranous LN.
Author Aya Nawata
Yoshiya Tanaka
Satoshi Hisano
Ke‐Yong Wang
Toshiyuki Nakayama
Shohei Shimajiri
Author_xml – sequence: 1
  givenname: Aya
  orcidid: 0000-0002-7871-2425
  surname: Nawata
  fullname: Nawata, Aya
  email: aya.y0116@gmail.com
  organization: University of Occupational and Environmental Health
– sequence: 2
  givenname: Satoshi
  surname: Hisano
  fullname: Hisano, Satoshi
  organization: Fukuoka University
– sequence: 3
  givenname: Shohei
  surname: Shimajiri
  fullname: Shimajiri, Shohei
  organization: University of Occupational and Environmental Health
– sequence: 4
  givenname: Ke‐Yong
  surname: Wang
  fullname: Wang, Ke‐Yong
  organization: University of Occupational and Environmental Health
– sequence: 5
  givenname: Yoshiya
  surname: Tanaka
  fullname: Tanaka, Yoshiya
  organization: University of Occupational and Environmental Health
– sequence: 6
  givenname: Toshiyuki
  surname: Nakayama
  fullname: Nakayama, Toshiyuki
  organization: University of Occupational and Environmental Health
BackLink https://cir.nii.ac.jp/crid/1873398392631685504$$DView record in CiNii
https://www.ncbi.nlm.nih.gov/pubmed/29247494$$D View this record in MEDLINE/PubMed
BookMark eNp1kc1uEzEUhS1UREPpghdAlmABi2mvf2e8RBXQSpVAAtbGsT2KK8cO9gxo3h6HJJsK7sLefOf6-Jzn6Czl5BF6SeCKtLnehHpFGBf8CVoRJkVHhVBnaAUMVAdE9ufostawBgo9kZKoZ-icKsp7rvgK_fiSXbbL5LFJDvvk8rTxMZiIrY8Rh_QwlwVHbxyeMk5-tyl5ChbXJbmSt74ReFdyDKMvZgq_PI7zbq4HMkyhvkBPRxOrvzzeF-j7xw_fbm67-8-f7m7e33eW84F3VFkwwgFQyrmlprnnnK4BPAczwCipHaRiigI1AzNCSKPAOWBErXurRnaB3h72Njc_Z18nvQ11_weTfJ6rJqpvM0hKG_r6EfqQ55KaO02BtVeIkqJRr47UvN56p3clbE1Z9Cm7BlwfAFtyrcWP2oapZZDTVEyImoDeF6RbQfpvQU3x7pHitPRf7HH77xD98n9Q3959PSneHBQphGZlf5KhZ0wNLTbJiByEAM7-AB59qAc
CitedBy_id crossref_primary_10_1097_IMNA_D_22_00016
crossref_primary_10_3389_fphar_2021_621300
crossref_primary_10_3389_fimmu_2023_1154552
crossref_primary_10_1681_ASN_2019080825
crossref_primary_10_1016_j_isci_2024_110350
crossref_primary_10_3389_fphar_2024_1477708
crossref_primary_10_1038_s41374_021_00591_9
crossref_primary_10_1155_2021_9993971
crossref_primary_10_1016_j_jep_2020_112789
crossref_primary_10_1002_path_6174
crossref_primary_10_1002_mco2_699
crossref_primary_10_1136_lupus_2024_001349
crossref_primary_10_1093_rheumatology_keaa474
Cites_doi 10.1172/JCI73168
10.1681/ASN.2009040453
10.59566/IJBS.2009.5028
10.1016/j.bbrc.2010.04.069
10.1007/s10157-013-0775-y
10.1016/j.humpath.2015.10.013
10.1152/ajprenal.00616.2014
10.1177/0961203310397412
10.1681/ASN.2004070564
10.1007/s00467-016-3379-4
10.1016/j.humpath.2010.05.028
10.2215/CJN.06720615
10.1177/0961203313517152
10.1016/j.amjmed.2008.11.025
10.1007/s00428-015-1821-9
10.1083/jcb.98.4.1591
10.1111/j.1523-1755.2004.00443.x
10.1097/01.ASN.0000078803.53165.C9
10.1053/j.ajkd.2004.10.020
10.1002/art.1780251101
10.1016/j.kint.2016.01.012
10.1152/ajprenal.00478.2012
10.1056/NEJMoa0810457
ContentType Journal Article
Copyright 2017 John Wiley & Sons Ltd
2017 John Wiley & Sons Ltd.
Copyright © 2018 John Wiley & Sons Ltd
Copyright_xml – notice: 2017 John Wiley & Sons Ltd
– notice: 2017 John Wiley & Sons Ltd.
– notice: Copyright © 2018 John Wiley & Sons Ltd
DBID RYH
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QP
7QR
7T5
7TK
7TM
8FD
FR3
H94
K9.
P64
RC3
7X8
DOI 10.1111/his.13454
DatabaseName CiNii Complete
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Calcium & Calcified Tissue Abstracts
Chemoreception Abstracts
Immunology Abstracts
Neurosciences Abstracts
Nucleic Acids Abstracts
Technology Research Database
Engineering Research Database
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Biotechnology and BioEngineering Abstracts
Genetics Abstracts
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Genetics Abstracts
Technology Research Database
Nucleic Acids Abstracts
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Chemoreception Abstracts
Immunology Abstracts
Engineering Research Database
Calcium & Calcified Tissue Abstracts
Neurosciences Abstracts
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

MEDLINE
Genetics Abstracts
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1365-2559
EndPage 1092
ExternalDocumentID 29247494
10_1111_his_13454
HIS13454
Genre article
Journal Article
GrantInformation_xml – fundername: Kitakyushu Medical Association
GroupedDBID ---
.3N
.GA
05W
0R~
10A
1OB
1OC
29I
33P
36B
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
5GY
5HH
5LA
5RE
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AAHQN
AAIPD
AAMNL
AANLZ
AAONW
AASGY
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABDBF
ABJNI
ABOCM
ABPVW
ABQWH
ABXGK
ACAHQ
ACCFJ
ACCZN
ACGFO
ACGFS
ACGOF
ACIWK
ACMXC
ACPOU
ACPRK
ACUHS
ACXBN
ACXQS
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
ADZOD
AEEZP
AEGXH
AEIGN
AEIMD
AENEX
AEQDE
AEUYR
AEYWJ
AFBPY
AFEBI
AFFPM
AFGKR
AFWVQ
AFZJQ
AGHNM
AGYGG
AHBTC
AIACR
AIAGR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ATUGU
AZBYB
AZVAB
BAFTC
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
EAD
EAP
EBC
EBD
EBS
EJD
EMB
EMK
EMOBN
ESX
EX3
F00
F01
F04
F5P
FUBAC
G-S
G.N
GODZA
H.X
HGLYW
HZI
HZ~
IHE
IX1
J0M
K48
KBYEO
L7B
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
Q.N
Q11
QB0
R.K
ROL
RX1
RYH
SUPJJ
SV3
TEORI
TUS
UB1
V8K
W8V
W99
WBKPD
WH7
WHWMO
WIH
WIJ
WIK
WOHZO
WOW
WQJ
WVDHM
WXI
WXSBR
XG1
YFH
YOC
YUY
ZZTAW
~IA
~WT
.55
.GJ
.Y3
31~
3UE
53G
AAKAS
AAMMB
AANHP
ABEML
ACBWZ
ACRPL
ACSCC
ACYXJ
ADNMO
ADZCM
AEFGJ
AFFNX
AGQPQ
AGXDD
AHEFC
AIDQK
AIDYY
AIQQE
ASPBG
AVWKF
AZFZN
BDRZF
CAG
COF
DC6
FEDTE
FZ0
GSXLS
HF~
HVGLF
J5H
PALCI
RIWAO
RJQFR
SAMSI
X7M
Y6R
ZGI
ZXP
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QP
7QR
7T5
7TK
7TM
8FD
FR3
H94
K9.
P64
RC3
7X8
ID FETCH-LOGICAL-c4484-29c0a5d002244c2a030442b00e40a80f62c86939202a83a556a90dd0319b7c9f3
IEDL.DBID DR2
ISSN 0309-0167
1365-2559
IngestDate Fri Jul 11 11:44:50 EDT 2025
Fri Jul 25 10:13:03 EDT 2025
Thu Apr 03 07:05:09 EDT 2025
Wed Oct 01 04:28:12 EDT 2025
Thu Apr 24 23:12:23 EDT 2025
Sun Sep 21 06:14:46 EDT 2025
Fri Jun 27 00:43:44 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 7
Keywords lupus nephritis
endothelial cell
nephrotic syndrome
podocyte
Language English
License 2017 John Wiley & Sons Ltd.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4484-29c0a5d002244c2a030442b00e40a80f62c86939202a83a556a90dd0319b7c9f3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-7871-2425
PMID 29247494
PQID 2036931965
PQPubID 1086360
PageCount 9
ParticipantIDs proquest_miscellaneous_1977778622
proquest_journals_2036931965
pubmed_primary_29247494
crossref_citationtrail_10_1111_his_13454
crossref_primary_10_1111_his_13454
wiley_primary_10_1111_his_13454_HIS13454
nii_cinii_1873398392631685504
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate June 2018
PublicationDateYYYYMMDD 2018-06-01
PublicationDate_xml – month: 06
  year: 2018
  text: June 2018
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
– name: Oxford
PublicationTitle Histopathology
PublicationTitleAlternate Histopathology
PublicationYear 2018
Publisher Wiley
Wiley Subscription Services, Inc
Publisher_xml – name: Wiley
– name: Wiley Subscription Services, Inc
References 2004; 65
2009; 20
2015; 467
2013; 304
2013; 123
2016; 31
2003; 14
2015; 308
2015; 8
2014; 23
2005; 45
2016; 11
1982; 25
2016; 1
2013; 17
1984; 98
2011; 42
2010; 396
2011; 20
2009; 122
2015
2009; 5
2009; 361
2005; 16
2016; 49
2016; 89
e_1_2_7_6_1
e_1_2_7_5_1
e_1_2_7_4_1
e_1_2_7_3_1
e_1_2_7_9_1
e_1_2_7_8_1
e_1_2_7_7_1
e_1_2_7_19_1
e_1_2_7_18_1
e_1_2_7_16_1
e_1_2_7_2_1
e_1_2_7_15_1
Nawata A (e_1_2_7_23_1) 2016; 1
e_1_2_7_14_1
e_1_2_7_12_1
e_1_2_7_11_1
e_1_2_7_10_1
e_1_2_7_26_1
Santos M (e_1_2_7_17_1) 2015; 8
e_1_2_7_27_1
D'Agati VD (e_1_2_7_25_1) 2015
e_1_2_7_24_1
e_1_2_7_22_1
e_1_2_7_21_1
e_1_2_7_20_1
Kubiak‐Wlekły A (e_1_2_7_13_1) 2009; 5
References_xml – volume: 8
  start-page: 4600
  year: 2015
  end-page: 4613
  article-title: Podocyte‐associated mRNA profiles in kidney tissue and in urine of patients with active lupus nephritis
  publication-title: Int. J. Clin. Exp. Pathol.
– volume: 1
  start-page: 1
  year: 2016
  end-page: 25
  article-title: Overexpression of peroxiredoxin 4 affects intestinal function in a dietary mouse model of nonalcoholic fatty liver disease
  publication-title: PLoS ONE
– volume: 304
  start-page: F333
  year: 2013
  end-page: F347
  article-title: The podocyte's response to stress: the enigma of foot process effacement
  publication-title: Am. J. Physiol. Renal Physiol.
– volume: 31
  start-page: 2179
  year: 2016
  end-page: 2189
  article-title: Pathogenesis of proteinuria in idiopathic minimal change disease: molecular mechanisms
  publication-title: Pediatr. Nephrol.
– volume: 23
  start-page: 255
  year: 2014
  end-page: 262
  article-title: Podocyte injury in pure membranous and proliferative lupus nephritis: distinct underlying mechanisms of proteinuria?
  publication-title: Lupus
– volume: 65
  start-page: 521
  year: 2004
  end-page: 530
  article-title: The classification of glomerulonephritis in systemic lupus erythematosus revised
  publication-title: Kidney Int.
– volume: 16
  start-page: 408
  year: 2005
  end-page: 416
  article-title: Apical cell membranes are shed into urine from injured podocytes: a novel phenomenon of podocyte injury
  publication-title: J. Am. Soc. Nephrol.
– volume: 308
  start-page: F614
  year: 2015
  end-page: F626
  article-title: Podocyte injury‐driven intracapillary plasminogen activator inhibitor type 1 accelerates podocyte loss via uPAR‐mediated β1‐integrin endocytosis
  publication-title: Am. J. Physiol. Renal Physiol.
– volume: 45
  start-page: 295
  year: 2005
  end-page: 302
  article-title: Activation of the lectin pathway in Henoch‐Schoenlein purpura nephritis
  publication-title: Am. J. Kidney Dis.
– volume: 25
  start-page: 1271
  year: 1982
  end-page: 1277
  article-title: The 1982 revised criteria for the classification of systemic lupus erythematosus
  publication-title: Arthritis Rheum.
– volume: 123
  start-page: 4996
  year: 2013
  end-page: 4999
  article-title: ADCK4 ‘reenergizes’ nephrotic syndrome
  publication-title: J. Clin. Invest.
– volume: 396
  start-page: 164
  year: 2010
  end-page: 169
  article-title: Molecular make‐up of the glomerular filtration barrier
  publication-title: Biochem. Biophys. Res. Commun.
– volume: 17
  start-page: 811
  year: 2013
  end-page: 818
  article-title: Reduced podocin expression in minimal change disease and focal segmental glomerulosclerosis is related to the level of proteinuria
  publication-title: Clin. Exp. Nephrol.
– volume: 11
  start-page: 585
  year: 2016
  end-page: 592
  article-title: Clinical‐morphological features and outcomes of lupus podocytopathy
  publication-title: Clin. J. Am. Soc. Nephrol.
– volume: 20
  start-page: 1425
  year: 2009
  end-page: 1427
  article-title: The promise of well‐being: stay in shape with N(i)ck
  publication-title: J. Am. Soc. Nephrol.
– volume: 467
  start-page: 449
  year: 2015
  end-page: 458
  article-title: Podocyte and endothelial injury in focal segmental glomerulosclerosis: an ultrastructural analysis
  publication-title: Virchow Arch.
– volume: 49
  start-page: 135
  year: 2016
  end-page: 144
  article-title: Endothelial cell injury in acute and chronic glomerular lesions in patients with IgA nephropathy
  publication-title: Hum. Pathol.
– volume: 14
  start-page: 2063
  year: 2003
  end-page: 2071
  article-title: Expression of podocyte‐associated molecules in acquired human kidney diseases
  publication-title: J. Am. Soc. Nephrol.
– volume: 5
  start-page: 28
  year: 2009
  end-page: 36
  article-title: The comparison of the podocyte expression of synaptopodin, CR1 and neprilysin in human glomerulonephritis: could the expression of CR1 be clinically relevant?
  publication-title: Int. J. Biomed. Sci.
– start-page: 559
  year: 2015
  end-page: 656
– volume: 42
  start-page: 227
  year: 2011
  end-page: 235
  article-title: Immunohistochemical evaluation of podocalyxin expression in glomerulopathies associated with nephrotic syndrome
  publication-title: Hum. Pathol.
– volume: 89
  start-page: 1221
  year: 2016
  end-page: 1230
  article-title: Podocyte injury and its consequences
  publication-title: Kidney Int.
– volume: 361
  start-page: 11
  year: 2009
  end-page: 21
  article-title: M‐type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy
  publication-title: N. Engl. J. Med.
– volume: 122
  start-page: 322
  year: 2009
  end-page: 328
  article-title: Renal effects of anti‐angiogenesis therapy: update for the internist
  publication-title: Am. J. Med.
– volume: 98
  start-page: 1591
  year: 1984
  end-page: 1596
  article-title: Identification and characterization of podocalyxin – the major sialoprotein of the renal glomerular epithelial cell
  publication-title: J. Cell Biol.
– volume: 20
  start-page: 781
  year: 2011
  end-page: 791
  article-title: Podocyte main slit diaphragm proteins, nephrin and podocin, are affected at early stages of lupus nephritis and correlate with disease histology
  publication-title: Lupus
– ident: e_1_2_7_8_1
  doi: 10.1172/JCI73168
– ident: e_1_2_7_10_1
  doi: 10.1681/ASN.2009040453
– volume: 5
  start-page: 28
  year: 2009
  ident: e_1_2_7_13_1
  article-title: The comparison of the podocyte expression of synaptopodin, CR1 and neprilysin in human glomerulonephritis: could the expression of CR1 be clinically relevant?
  publication-title: Int. J. Biomed. Sci.
  doi: 10.59566/IJBS.2009.5028
– start-page: 559
  volume-title: Heptinstall's pathology of the kidney
  year: 2015
  ident: e_1_2_7_25_1
– ident: e_1_2_7_5_1
  doi: 10.1016/j.bbrc.2010.04.069
– ident: e_1_2_7_9_1
  doi: 10.1007/s10157-013-0775-y
– ident: e_1_2_7_26_1
  doi: 10.1016/j.humpath.2015.10.013
– ident: e_1_2_7_12_1
  doi: 10.1152/ajprenal.00616.2014
– ident: e_1_2_7_14_1
  doi: 10.1177/0961203310397412
– volume: 8
  start-page: 4600
  year: 2015
  ident: e_1_2_7_17_1
  article-title: Podocyte‐associated mRNA profiles in kidney tissue and in urine of patients with active lupus nephritis
  publication-title: Int. J. Clin. Exp. Pathol.
– ident: e_1_2_7_21_1
  doi: 10.1681/ASN.2004070564
– ident: e_1_2_7_7_1
  doi: 10.1007/s00467-016-3379-4
– ident: e_1_2_7_2_1
  doi: 10.1016/j.humpath.2010.05.028
– ident: e_1_2_7_3_1
  doi: 10.2215/CJN.06720615
– ident: e_1_2_7_16_1
  doi: 10.1177/0961203313517152
– volume: 1
  start-page: 1
  year: 2016
  ident: e_1_2_7_23_1
  article-title: Overexpression of peroxiredoxin 4 affects intestinal function in a dietary mouse model of nonalcoholic fatty liver disease
  publication-title: PLoS ONE
– ident: e_1_2_7_27_1
  doi: 10.1016/j.amjmed.2008.11.025
– ident: e_1_2_7_24_1
  doi: 10.1007/s00428-015-1821-9
– ident: e_1_2_7_11_1
  doi: 10.1083/jcb.98.4.1591
– ident: e_1_2_7_18_1
  doi: 10.1111/j.1523-1755.2004.00443.x
– ident: e_1_2_7_15_1
  doi: 10.1097/01.ASN.0000078803.53165.C9
– ident: e_1_2_7_22_1
  doi: 10.1053/j.ajkd.2004.10.020
– ident: e_1_2_7_19_1
  doi: 10.1002/art.1780251101
– ident: e_1_2_7_4_1
  doi: 10.1016/j.kint.2016.01.012
– ident: e_1_2_7_6_1
  doi: 10.1152/ajprenal.00478.2012
– ident: e_1_2_7_20_1
  doi: 10.1056/NEJMoa0810457
SSID ssib020716619
ssib050995417
ssib006544801
ssib002399368
ssib006544800
ssib004261719
ssib058492894
ssj0017322
Score 2.3037038
Snippet Aims Nephrotic syndrome (NS) is a major manifestation of lupus nephritis (LN). The dysregulation of podocytes, the glomerular basement membrane (GBM) and...
Nephrotic syndrome (NS) is a major manifestation of lupus nephritis (LN). The dysregulation of podocytes, the glomerular basement membrane (GBM) and...
AimsNephrotic syndrome (NS) is a major manifestation of lupus nephritis (LN). The dysregulation of podocytes, the glomerular basement membrane (GBM) and...
SourceID proquest
pubmed
crossref
wiley
nii
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1084
SubjectTerms Adolescent
Adult
Aged
Cell injury
Child
Disease Progression
Electron microscopy
endothelial cell
Endothelial Cells
Endothelial Cells - metabolism
Endothelial Cells - pathology
Female
Gene expression
Hematuria
Humans
Immunohistochemistry
Kidney diseases
Kidney Glomerulus
Kidney Glomerulus - metabolism
Kidney Glomerulus - pathology
Lupus Nephritis
Lupus Nephritis - complications
Lupus Nephritis - metabolism
Lupus Nephritis - pathology
Male
Membranous nephropathy
Microfilament Proteins
Microfilament Proteins - metabolism
Middle Aged
Nephritis
Nephropathy
Nephrotic Syndrome
Nephrotic Syndrome - etiology
Nephrotic Syndrome - metabolism
Nephrotic Syndrome - pathology
podocyte
Podocytes
Podocytes - metabolism
Podocytes - pathology
Polymerase chain reaction
Proteinuria
Proteinuria - metabolism
Proteinuria - pathology
Reverse transcription
Sialoglycoproteins
Sialoglycoproteins - metabolism
Tumors
WT1 Proteins
WT1 Proteins - metabolism
Young Adult
Title Podocyte and endothelial cell injury lead to nephrotic syndrome in proliferative lupus nephritis
URI https://cir.nii.ac.jp/crid/1873398392631685504
https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fhis.13454
https://www.ncbi.nlm.nih.gov/pubmed/29247494
https://www.proquest.com/docview/2036931965
https://www.proquest.com/docview/1977778622
Volume 72
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVEBS
  databaseName: EBSCOhost Academic Search Ultimate
  customDbUrl: https://search.ebscohost.com/login.aspx?authtype=ip,shib&custid=s3936755&profile=ehost&defaultdb=asn
  eissn: 1365-2559
  dateEnd: 20241003
  omitProxy: true
  ssIdentifier: ssj0017322
  issn: 0309-0167
  databaseCode: ABDBF
  dateStart: 19980101
  isFulltext: true
  titleUrlDefault: https://search.ebscohost.com/direct.asp?db=asn
  providerName: EBSCOhost
– providerCode: PRVWIB
  databaseName: Wiley Online Library - Core collection (SURFmarket)
  issn: 0309-0167
  databaseCode: DR2
  dateStart: 19970101
  customDbUrl:
  isFulltext: true
  eissn: 1365-2559
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0017322
  providerName: Wiley-Blackwell
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VHhAXWh4t2wcyiEMvWSWOndjqqUJUCxIIAZV6QAqO44iFlXfVTQ7tr--M84CiVqq4RJE8sRzPjGfGM_4M8KY2aPUro6I8zk1E6C-RUsJGSWYSh_xGKxMKZD9lszPx4Vyeb8DxcBamw4cYN9xIM8J6TQpuyvVfSv5zvp4mqZCEBZqkMqRov4zQUUme_skgUKl9jypEVTzjlzds0QM_n9_mZt70WoPZOd2C78OAu2qT39O2Kaf26h8sx__8o2143Luj7KSTnyew4fxTePixT7g_gx-fMWy1l41jxlfM-YoObC1QZhnt-LO5_4U8YQsUFNYsmXcoGkvsig1ACEjBVnQxUO06iHG2aFftuqMkOKXncHb67tvbWdRfyhBZjORExLWNjayC7ReWG0qtCo7K60RsVFxn3KpMo9cVc6NSI2VmdFxVdFiqzK2u0x3Y9EvvXgAT2J44p3Nd18KVdSlLLmvFLQHESGcmcDSwp7A9YjldnLEohsgFZ6wIMzaB1yPpqoPpuI3oEHmMXdEzUXmaanIPM7q7CwM1bD8YuF_0mrwuKFGraZ2SE3g1NqMO0jQb75Yt9o5ONOHwcT6B3U5qxlFwDHBzobHzo8D7u4dXzN5_DS979yfdh0fowamudu0ANpuL1h2il9SUL4M6XANzxQkT
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB61RYJeeD-WtmAQh16yShw7saVeUEu1hbZC0Eq9oOA4jtiy8q7Y5EB_fWfyglZFqrhEkTyxHM-MZ8Yz_gzwrjRo9QujgjRMTUDoL4FSwgZRYiKH_EYr0xTIHieTU_HxTJ6twE5_FqbFhxg23EgzmvWaFJw2pP_S8h_T5TiKhRSrcIfyc6SWe18G8Kgojf_kEKjYvsMVojqe4dMr1mjVT6c3OZpX_dbG8Ow_gG_9kNt6k5_jusrH9uIamuP__tNDuN95pOx9K0KPYMX5x3D3qMu5P4HvnzFytb8rx4wvmPMFndmaodgy2vRnU3-ObGEzlBVWzZl3KB1z7Ir1WAhIwRZ0N1DpWpRxNqsX9bKlJESlp3C6_-FkdxJ09zIEFoM5EXBtQyOLxvwLyw1lVwVH_XUiNCosE25VotHxCrlRsZEyMTosCjovladWl_EzWPNz714AE9geOadTXZbC5WUucy5LxS1hxEhnRrDd8yezHWg53Z0xy_rgBWcsa2ZsBG8H0kWL1HET0RYyGbuiZ6TSONbkISZ0fRfGati-2bM_65R5mVGuVtNSJUfwZmhGNaRpNt7Na-wd_WiC4uN8BM9bsRlGwTHGTYXGzrcb5v97eNnk4Gvz8vL2pK_h3uTk6DA7PDj-tAHr6NCptpRtE9aqX7XbQqepyl81unEJBOgNLw
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB61Raq48H4stGAQh16yShw7scUJAastj6oCKvWAFBzHFtuuvCs2OcCvZyYvKCoS4hJF8sRyPDOZb-LxZ4Bn3mDUr4yK8jg3EbG_REoJGyWZSRzqG6NMWyB7lM1PxJtTeboFz4e9MB0_xPjDjTyj_V6Tg68r_5uTf11spkkqpNiGKyLD7IoQ0YeROyrJ019LCFRr39MKURnP-OiFYLQdFovLcOZF2NrGndl1-DyMuCs3OZ82dTm1P_4gc_zPV7oB13o8yl50BnQTtly4Bbvv-xX32_DlGPNW-712zISKuVDRjq0lGi2jX_5sEc5QKWyJlsLqFQsObWOFXbGBCQEl2JpOBvKu4xhny2bdbDpJ4lO6Ayez159ezqP-VIbIYionIq5tbGTVBn9huaG1VcHRe52IjYp9xq3KNMKumBuVGikzo-Oqot1SZW61T-_CTlgFdx-YwPbEOZ1r74UrfSlLLr3ilhhipDMTOBjUU9iespxOzlgWQ-qCM1a0MzaBp6PouuPpuExoH3WMXdE1UXmaasKHGR3ehZkatu8N2i96V94UtFKr6UMlJ_BkbEYnpGk2wa0a7B1RNBHxcT6Be53VjKPgmOHmQmPnB63u_z68Yn74sb158O-ij2H3-NWseHd49PYhXEU0p7o6tj3Yqb81bh8RU10-aj3jJ83aC94
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Podocyte+and+endothelial+cell+injury+lead+to+nephrotic+syndrome+in+proliferative+lupus+nephritis&rft.jtitle=Histopathology&rft.au=Nawata%2C+Aya&rft.au=Hisano%2C+Satoshi&rft.au=Shimajiri%2C+Shohei&rft.au=Wang%2C+Ke%E2%80%90Yong&rft.date=2018-06-01&rft.issn=0309-0167&rft.eissn=1365-2559&rft.volume=72&rft.issue=7&rft.spage=1084&rft.epage=1092&rft_id=info:doi/10.1111%2Fhis.13454&rft.externalDBID=n%2Fa&rft.externalDocID=10_1111_his_13454
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0309-0167&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0309-0167&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0309-0167&client=summon